Neostigmine Impurity 8 Methylsulfate, with the CAS number 39218-17-2, is a chemical compound that is typically associated with the pharmaceutical industry, particularly in relation to the synthesis and quality control of neostigmine, a medication used to treat myasthenia gravis and to reverse the effects of certain muscle relaxants. This impurity is characterized by its structural features, which include a methylsulfate group that can influence its solubility and reactivity. As an impurity, it may arise during the synthesis of neostigmine and can affect the overall purity and efficacy of the final pharmaceutical product. The presence of such impurities is critical to monitor, as they can impact the safety and effectiveness of medications. Analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry are often employed to identify and quantify impurities like Neostigmine Impurity 8 Methylsulfate in pharmaceutical formulations. Understanding the characteristics of this impurity is essential for ensuring compliance with regulatory standards and maintaining drug quality.

Neostigmine Impurity 8 Metilsulfate

39218-17-2: Neostigmine Impurity 8 Methylsulfate, with the CAS number 39218-17-2, is a chemical compound that is typically associated with the pharmaceutical industry, particularly in relation to the synthesis and quality control of neostigmine, a medication used to treat myasthenia gravis and to reverse the effects of certain muscle relaxants. This impurity is characterized by its structural features, which include a methylsulfate group that can influence its solubility and reactivity. As an impurity, it may arise during the synthesis of neostigmine and can affect the overall purity and efficacy of the final pharmaceutical product. The presence of such impurities is critical to monitor, as they can impact the safety and effectiveness of medications. Analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry are often employed to identify and quantify impurities like Neostigmine Impurity 8 Methylsulfate in pharmaceutical formulations. Understanding the characteristics of this impurity is essential for ensuring compliance with regulatory standards and maintaining drug quality.

CAS 39218-17-2

Neostigmine Impurity 8 Metilsulfate

Neostigmine Impurity 8 Metilsulfate

Ref: 4Z-N-4911

Neostigmine Impurity 2 Metilsulfate

Ref: ST-EA-CP-N33010